Xiamen Amoytop Biotech Co Ltd (688278) — Capital Reinvestment Ratio
Latest as of September 2023:
0.13x
Xiamen Amoytop Biotech Co Ltd (688278) has a Capital Reinvestment Ratio of 0.13x as of September 2023, meaning it reinvests 0% of its operating cash flow (CN¥332.29 Million) in capital expenditures (CN¥43.00 Million). See 688278 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.13x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥332.29 Million
CNY
Capital Expenditures
CN¥43.00 Million
CNY
Data as of
Sep 2023
Most recent filing
Xiamen Amoytop Biotech Co Ltd Capital Reinvestment Ratio (2016–2024)
This chart tracks Xiamen Amoytop Biotech Co Ltd's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for Xiamen Amoytop Biotech Co Ltd (2016–2024)
Year-by-year Capital Reinvestment Ratio for Xiamen Amoytop Biotech Co Ltd from 2016 to 2024. For live market cap and broader valuation context, see how much is Xiamen Amoytop Biotech Co Ltd worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.58x | CN¥430.63 Million | CN¥251.35 Million | ▲ +22.3% |
| 2023 | 0.48x | CN¥512.10 Million | CN¥244.48 Million | ▼ -20.9% |
| 2022 | 0.60x | CN¥363.16 Million | CN¥219.17 Million | ▼ -25.8% |
| 2021 | 0.81x | CN¥234.78 Million | CN¥190.93 Million | ▼ -36.6% |
| 2020 | 1.28x | CN¥92.61 Million | CN¥118.81 Million | ▲ +252.9% |
| 2019 | 0.36x | CN¥123.30 Million | CN¥44.83 Million | ▲ +122.0% |
| 2018 | 0.16x | CN¥89.15 Million | CN¥14.60 Million | ▼ -92.0% |
| 2016 | 2.05x | CN¥42.43 Million | CN¥87.03 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow